Superworth

SpyGlass Pharma SGP

Medical - Instruments & Supplies, Healthcare
$28.48
+0.92%
Market cap
$952.6M
PE
n/m
one or more of the four quarters through 2026-06-30 missing
Forward PE
n/m
not a meaningful number
Price to sales
n/m
not a meaningful number
EV/EBIT
n/m
not a meaningful number
Revenue, 12 months
n/m
not a meaningful number
Net margin
n/m
not a meaningful number
Free cash flow yield
n/m
not a meaningful number

Charts

Financials

Income statement for SGP, by quarter
Income statementQ1 FY25Q2 FY25Q1 FY26Q2 FY26
R&D$6.1M$7.3M$8.5M$10.9M
SG&A$1.4M$2M$6.9M$11M
−$7.4M−$9.3M−$15.4M−$22M
Pre-tax income−$8.8M−$8.7M−$13.8M−$19.9M
$0$0$0$0
Net income−$8.8M−$8.7M−$13.8M−$19.9M
−$3.96−$3.81−$0.69−$0.59
2.2M2.3M19.9M33.4M

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Peers

Companies in Medical - Instruments & Supplies nearest SpyGlass Pharma's size, closest first.

CompanyMarket capPEIts 10y median PEFwd PEP/SRevenue growthNet margin
SGPSpyGlass Pharma$952.6Mn/mn/an/mn/mn/m
IRMDIradimed$1.1B47.9×41.4×12.7×+11%26.7%
STAAStaar Surgical$1.1B323×143×3.3×+51%1.1%
BVSBioventus$1.3B19.4×27.2×2.2×+3%9.4%
CDRECadre$1.3B37.0×35.8×1.9×+20%5.3%
MOVMovado$701.9M17.5×13.3×1.0×+5%6.0%
EYENational Vision$1.5B30.6×53.3×0.7×+8%2.5%
MDXGMimedx$569.9M97.8×21.1×1.6×−2%1.8%
TCMDTactile Systems Technology$535.5M21.9×62.9×1.5×+17%7.1%
LMATLemaitre Vascular$1.9B29.6×42.0×7.4×+12%25.0%
INSPInspire Medical Systems$2.1B15.4×58.0×2.3×+4%15.0%
Peer median$1.2B30.1×41.7×2.0×+10%6.5%

More on SpyGlass Pharma

Each number over time

Its groups

About

Industry
Medical - Instruments & Supplies
Sector
Healthcare

Valuation data, not investment advice. Prices as of .